DOJ Probes Andreessen Horowitz Board Seats as VCs Defend Unavoidable Conflicts

TL;DR
- The Department of Justice has opened an antitrust probe into Andreessen Horowitz focused on whether overlapping board seats across its portfolio companies violate federal prohibitions on interlocking directorates.
- Many venture capitalists are pushing back on the investigation, arguing that startups frequently pivot into competing markets, making overlapping investments and board conflicts nearly impossible to avoid at scale.
- The outcome could force a major shift in how large VC firms handle board governance, disclosures, and investment strategy as regulatory scrutiny of Silicon Valley intensifies.
The Probe That Has Silicon Valley Talking
The Justice Department is taking a closer look at one of Silicon Valley's most powerful venture firms. Regulators have launched an antitrust inquiry into Andreessen Horowitz, examining whether partners holding board seats on multiple portfolio companies creates illegal conflicts of interest.
At the center of the investigation is Section 8 of the Clayton Act, a century-old antitrust law that prohibits a person from serving on the boards of two competing corporations. While the law has historically been applied to large public companies, the DOJ under recent administrations has revived its enforcement and expanded its focus to include private markets, venture capital, and interlocking directorates in the tech sector.
According to reports, investigators are examining whether Andreessen Horowitz partners simultaneously sat on the boards of companies that later became direct competitors, and whether those overlapping roles gave the firm access to competitively sensitive information or influence over corporate strategy.
Neither the DOJ nor Andreessen Horowitz has publicly confirmed the full scope of the inquiry, but the probe is understood to be in its early stages and has not resulted in any formal allegations of wrongdoing.
Why VCs Say This Misses How Venture Actually Works
Across Sand Hill Road, the reaction has been largely one of bewilderment. Several prominent investors have privately and publicly argued that the investigation misunderstands the fundamental nature of venture capital.
Unlike public market investing, venture firms often back companies years before their ultimate business model is clear. A seed-stage startup focused on fintech infrastructure today could pivot to become an AI-powered enterprise software competitor tomorrow. For a firm like Andreessen Horowitz, which manages tens of billions in assets and holds stakes in hundreds of companies, that kind of convergence is not just possible, it's expected.
Venture capitalists argue that backing multiple companies in a broad sector like AI, crypto, or enterprise SaaS is standard practice, and that portfolio companies routinely evolve to overlap. To enforce a strict interpretation of interlocking directorates in this environment, they say, would require firms to either take far fewer board seats, divest from promising companies at the first sign of competition, or avoid entire categories altogether.
One early-stage investor described the situation as an "unavoidable feature, not a bug" of building a diversified portfolio in fast-moving technology markets. Others note that VC board members are typically bound by confidentiality and fiduciary duties and often recuse themselves when sensitive competitive issues arise.
A Test Case for VC Board Governance
Whether or not the DOJ pursues enforcement action, the probe is already raising difficult questions about board governance in venture-backed companies.
Traditionally, taking a board seat has been the primary way venture firms protect their investment, mentor founders, and stay informed about company performance. If regulators begin to view multiple board seats within a single sector as a potential antitrust risk, large firms may need to rethink that model.
Legal experts say firms could be forced to adopt more formal safeguards, including stricter information barriers between portfolio companies, more robust recusal policies, and earlier resignation from boards when a competitive overlap emerges. Some firms may also shift toward board observer roles, which carry less formal power but also less regulatory exposure, or rely more heavily on independent directors.
For founders, the shift could be double-edged. While fewer interlocks could reduce the risk of conflicts, it could also mean less access to the hands-on expertise and networks that top-tier VCs promise when they lead a round.
What Increased Scrutiny Could Mean for Investment Strategy
The broader implication goes beyond Andreessen Horowitz. The DOJ has in recent years signaled a more aggressive stance on interlocking directorates, forcing resignations at several large public companies and warning that it will not ignore violations in private markets.
If that scrutiny becomes the new normal for venture capital, it could fundamentally alter investment strategy for the largest firms. Mega-firms that pride themselves on backing every promising player in a hot sector like generative AI may face pressure to be more selective, ring-fencing teams and partners to avoid cross-portfolio conflicts.
Smaller, more thesis-driven funds could benefit, as they are less likely to hold competing board seats. At the same time, critics warn that over-enforcement could chill investment and make it harder for startups to secure capital from the most experienced investors.
For now, the industry is watching closely to see whether the Andreessen Horowitz probe remains a narrow inquiry or becomes a precedent-setting case. The answer will help determine whether overlapping board seats remain a standard part of the venture playbook or become a regulatory liability that firms can no longer afford to ignore.
Get All The Latest Updates Delivered Straight To Your Inbox For Free!